Doctornow

ActiveOn the South Korea Radar · not ranked

Telemedicine and e-pharmacy

Last roundSeries B follow-on · 2025

Why Doctornow is not ranked yet

The Radar lists every known eligible company, sorted by date of last round, with no AI judgement. Doctornow enters the ranking once its public data is sufficient for the AI to estimate it. Next South Korea edition: 18 Oct 2026.

Funding history

Date	Round	Amount	Type	Investors	Source
2025	Series B follow-on	undisclosed	—	Hashed, Mirae Asset	dailymedi.com

Last disclosed: USD ~32M (KRW 40bn), Jun 2022.

Rounds as cited by Uback’s rankings and their sources. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
South Korea · all sectors	Radar	—	Edition 0 – beta · October 2026	18 Oct 2026

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Doctornow as a PDF, on one of three angles only:

ValuationWhat is Doctornow worth?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication and never change the rank.

Invest

Doctornow is not open to Backers. A company opens only when a shareholder plans to sell or the company plans to raise.

Back the market instead: your intention joins a pool, passed to the local partner once it reaches critical mass.

Declare an interest in South Korean startups Declare an interest in South Korean healthtech Name Doctornow as a preferred company (measures demand, promises nothing)

South Korea poolBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until its pool is passed on. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run Doctornow?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round. Claiming never changes the rank.

Claim this profile Report an upcoming round →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Press & investor announcements1 source

Read by the AI at the next edition.

Comparable companies in South Korea

Full South Korea ranking →

Promedius#35Healthtech › AI osteoporosis screeningTens of M$Toss#1Fintech › financial super-appDecacorn Yanolja#2Travel › travel super-app and hospitality cloudUnicorn Musinsa#3Commerce › fashion e-commerce and retailUnicorn

Investors in Doctornow: Hashed · Mirae Asset

Sources. dailymedi.com

Last updated: Oct 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.